Table of Contents
List of Tables
List of Figures
1 Introduction
1.1 What Is This Report About?
1.2 Electrophysiology Devices Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Electrophysiology Devices Market, North America
2.1 Electrophysiology Devices Market, North America, Revenue ($m), 2024-2036
2.2 Electrophysiology Devices Market, North America, Revenue ($m), 2024-2036
2.3 Electrophysiology Devices Market, North America, Volume (Units), 2024-2036
2.4 Electrophysiology Devices Market, North America, Volume (Units), 2024-2036
2.5 Electrophysiology Devices Market, North America, Company Share by Revenue ($m), 2025
3 Electrophysiology Devices Market, Canada
3.1 Electrophysiology Devices Market, Canada, Revenue ($m), 2024-2036
3.1.1 Electrophysiology Ablation Catheters Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.2 Electrophysiology Diagnostic Catheters Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.3 Electrophysiology Lab Systems Market, Canada, Revenue ($m), by Segment, 2024-2036
3.2 Electrophysiology Devices Market, Canada, Volume (Units), 2024-2036
3.2.1 Electrophysiology Ablation Catheters Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.2 Electrophysiology Diagnostic Catheters Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.3 Electrophysiology Lab Systems Market, Canada, Volume (Units), by Segment, 2024-2036
3.3 Electrophysiology Devices Market, Canada, Average Price ($), 2024-2036
3.4 Electrophysiology Devices Market, Canada, Company Share by Revenue ($m), 2025
4 Electrophysiology Devices Market, Mexico
4.1 Electrophysiology Devices Market, Mexico, Revenue ($m), 2024-2036
4.1.1 Electrophysiology Ablation Catheters Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.2 Electrophysiology Diagnostic Catheters Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.3 Electrophysiology Lab Systems Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.2 Electrophysiology Devices Market, Mexico, Volume (Units), 2024-2036
4.2.1 Electrophysiology Ablation Catheters Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.2 Electrophysiology Diagnostic Catheters Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.3 Electrophysiology Lab Systems Market, Mexico, Volume (Units), by Segment, 2024-2036
4.3 Electrophysiology Devices Market, Mexico, Average Price ($), 2024-2036
4.4 Electrophysiology Devices Market, Mexico, Company Share by Revenue ($m), 2025
5 Electrophysiology Devices Market, United States
5.1 Electrophysiology Devices Market, United States, Revenue ($m), 2024-2036
5.1.1 Electrophysiology Ablation Catheters Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.2 Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.3 Electrophysiology Lab Systems Market, United States, Revenue ($m), by Segment, 2024-2036
5.2 Electrophysiology Devices Market, United States, Volume (Units), 2024-2036
5.2.1 Electrophysiology Ablation Catheters Market, United States, Volume (Units), by Segment, 2024-2036
5.2.2 Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), by Segment, 2024-2036
5.2.3 Electrophysiology Lab Systems Market, United States, Volume (Units), by Segment, 2024-2036
5.3 Electrophysiology Devices Market, United States, Average Price ($), 2024-2036
5.4 Electrophysiology Devices Market, United States, Company Share by Revenue ($m), 2025
6 Electrophysiology Devices Market Pipeline Products
6.1 Electrophysiology Devices Market Pipeline Products
6.2 Electrophysiology Devices – Pipeline Products by Stage of Development
6.3 Electrophysiology Devices – Pipeline Products by Segment
6.4 Electrophysiology Devices – Pipeline Products by Territory
6.5 Electrophysiology Devices – Pipeline Products by Regulatory Path
6.6 Electrophysiology Devices – Pipeline Products by Estimated Approval Date
7 Overview of Key Companies in North America Electrophysiology Devices Market
7.1 Biosense Webster Inc
7.1.1 Company Overview
7.2 Boston Scientific Corp
7.2.1 Company Overview
7.3 Medtronic Plc
7.3.1 Company Overview
7.4 Abbott Laboratories
7.4.1 Company Overview
7.5 Siemens Healthineers AG
7.5.1 Company Overview
7.6 GE HealthCare Technologies Inc
7.6.1 Company Overview
8 Recent Developments
8.1 Corporate Communications
8.1.1 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range
8.1.2 Nov 24, 2025: CPR Therapeutics Receives U.S. Patent for Advances in Cardioversion and Pacing
8.1.3 Nov 13, 2025: Cleveland Clinic Pitch Competition Awards $100,000 Grant to AutoCMR Inventors
8.1.4 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.1.5 Nov 10, 2025: Dr. Felicitas Koller Named Inaugural Hardy-Raju Chair of Transplant Surgery
8.1.6 Nov 05, 2025: IU Fuels Indiana’s Next Wave of Industry Growth
8.1.7 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
8.1.8 Nov 01, 2025: Dale Medical Products, Inc. Introduces IV Line Manager
8.1.9 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
8.1.10 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.1.11 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
8.1.12 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.1.13 Oct 26, 2025: Jupiter Endovascular Reports Positive Results From SPIRARE I First-in-Human Study
8.1.14 Oct 24, 2025: Payman Khales Becomes Integer President and CEO
8.1.15 Oct 23, 2025: Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System
8.1.16 Oct 21, 2025: Burl Concepts Closes Oversubscribed $4.5 Million Investment
8.1.17 Oct 20, 2025: Adagio Medical Secures $19 Million Financing to Enhance Ventricular Tachycardia Treatment Technology
8.1.18 Oct 15, 2025: WHO prequalifies two BD Onclarity HPV Assays for automated high-risk HPV detection, including individual genotyping for critical types
8.1.19 Oct 08, 2025: Mass General Brigham Invests $9 Million to Address Food Insecurity in Greater Boston
8.1.20 Oct 01, 2025: Cirtec Medical Appoints Steven Chevillotte To Board Of Directors
8.1.21 Sep 29, 2025: Bridge to Life Appoints David Castiglioni as Chief Commercial Officer
8.1.22 Sep 16, 2025: Cirtec Medical Welcomes Chris Cleary to its Board of Directors
8.1.23 Sep 10, 2025: UMaine Opens Labs to SMCC Students for Biomedical Engineering Research
8.1.24 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
8.1.25 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
8.2 Financial Announcements
8.2.1 Apr 28, 2026: Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026
8.2.2 Apr 02, 2026: Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026
8.2.3 Mar 12, 2026: Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results
8.2.4 Feb 24, 2026: Merit Medical Reports Fourth Quarter and Full-Year 2025 Results, Provides Fiscal 2026 Guidance
8.2.5 Jan 08, 2026: Merit Medical Appoints F. Ann Millner as Chair of the Board and Provides Preliminary Q4 2025 Revenue Range
8.2.6 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
8.2.7 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.2.8 Nov 11, 2025: Stereotaxis Reports 2025 Third Quarter Financial Results
8.2.9 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.2.10 Oct 30, 2025: Harvard Bioscience Schedules Third Quarter Earnings Conference Call
8.2.11 Oct 08, 2025: AtriCure To Announce Third Quarter Financial Results
8.2.12 Oct 03, 2025: Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
8.2.13 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results
8.2.14 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
8.2.15 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
8.2.16 Jul 03, 2025: Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
8.3 Government and Public Interest
8.3.1 Apr 28, 2026: AtriCure to Participate in 2026 Bank of America Securities Health Care Conference
8.3.2 Apr 27, 2026: GE HealthCare Management to Present at Upcoming Investor Conferences
8.3.3 Mar 03, 2026: Harvard Bioscience to Participate in KeyBanc Capital Markets Virtual Healthcare Forum
8.3.4 Nov 24, 2025: Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference
8.3.5 Nov 18, 2025: AtriCure to Participate in Piper Sandler 37th Annual Healthcare Conference
8.3.6 Nov 17, 2025: GE HealthCare Management to Present at Upcoming Investor Conference
8.3.7 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
8.3.8 Oct 27, 2025: AtriCure to Participate in Upcoming Investor Conferences
8.3.9 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium
8.3.10 Sep 25, 2025: Integer Announces Conference Call to Discuss Third Quarter 2025 Results
8.3.11 Sep 02, 2025: Autonomix Medical to Present at H.C. Wainwright 27th Annual Global Investment Conference
8.3.12 Aug 21, 2025: GE HealthCare Management to Present at Upcoming Investor Conferences
8.3.13 Aug 20, 2025: AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
8.3.14 Aug 12, 2025: Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4
8.3.15 Jul 28, 2025: AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
8.3.16 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
8.4 Legal And Regulatory
8.4.1 May 14, 2025: BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders
8.5 Other Significant Developments
8.5.1 Mar 30, 2026: UAMS Health Adds Cardiac Electrophysiology Services at Fort Smith Family Medical Center
8.5.2 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months
8.5.3 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
8.5.4 Nov 13, 2025: Cleveland Clinic Pitch Competition Awards $100,000 Grant to AutoCMR Inventors
8.5.5 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.5.6 Nov 05, 2025: IU Fuels Indiana’s Next Wave of Industry Growth
8.5.7 Nov 04, 2025: Vir Biotechnology concludes Eclipse 1 Phase III trial enrolment for CHD
8.5.8 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.5.9 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.5.10 Oct 16, 2025: University Of Maryland, Baltimore And Axis Research & Technologies Announce Joint Venture To Build Nation's First AI-Powered Smart Surgical Performance Center
8.5.11 Oct 09, 2025: BMES Launches Campaign to Elevate Biomedical Engineering Breakthroughs
8.5.12 Sep 10, 2025: OEM Toll Processing Enhances High-Value Products
8.6 Product News
8.6.1 Feb 18, 2026: NA Homolce to Become 3rd Site for VISABL-VT
8.6.2 Jan 28, 2026: Integer to Highlight Integrated R&D Solutions and Expanded Coating Capabilities at MD&M West 2026
8.6.3 Dec 30, 2025: Autonomix Medical Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology
8.6.4 Nov 30, 2025: Abbott Electrophysiology Online Training Courses
8.6.5 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
8.6.6 Nov 24, 2025: CPR Therapeutics Receives U.S. Patent for Advances in Cardioversion and Pacing
8.6.7 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared
8.6.8 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months
8.6.9 Nov 17, 2025: Terumo Aortic Launches Fenestrated TREO Pivotal IDE Study in the United States
8.6.10 Nov 12, 2025: VitAA Medical Receives FDA Clearance for AiORTA Plan in Aortic Care
8.6.11 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.6.12 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.6.13 Nov 05, 2025: Fluid Control Solutions For MedTech
8.6.14 Nov 04, 2025: AVS Reports Positive Safety and Effectiveness Data from Pulse IVL IDE Study
8.6.15 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
8.6.16 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
8.6.17 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.6.18 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
8.6.19 Oct 26, 2025: Jupiter Endovascular Reports Positive Results From SPIRARE I First-in-Human Study
8.6.20 Oct 24, 2025: Yorlabs Receives FDA 510(k) Clearance for Zero-CapEx Intracardiac Imaging System
8.6.21 Oct 23, 2025: Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System
8.6.22 Oct 22, 2025: Norav Medical Launches TeleEVENT – Full Disclosure Event Recorder for Remote Cardiac Telemetry
8.6.23 Oct 21, 2025: Burl Concepts Closes Oversubscribed $4.5 Million Investment
8.6.24 Oct 20, 2025: Adagio Medical Secures $19 Million Financing to Enhance Ventricular Tachycardia Treatment Technology
8.6.25 Oct 09, 2025: BMES Launches Campaign to Elevate Biomedical Engineering Breakthroughs
8.6.26 Oct 08, 2025: Izotropic Highlights Gaps in Breast Cancer Care During Awareness Month
8.6.27 Oct 01, 2025: Adagio Medical Completes Enrollment in FULCRUM-VT Clinical Trial for Ventricular Tachycardia
8.6.28 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium
8.6.29 Sep 29, 2025: Bridge to Life Appoints David Castiglioni as Chief Commercial Officer
8.6.30 Sep 29, 2025: Axon Introduces Axon Body Workforce Mini to Enhance Safety for Frontline Workers
8.6.31 Sep 28, 2025: Acoramidis Reduces Cardiovascular Outcomes in ATTR-CM Patients Within the First Month
8.6.32 Sep 10, 2025: OEM Toll Processing Enhances High-Value Products
8.6.33 Sep 09, 2025: Neurescue Device Receives CE Mark Approval for Non-Shockable Cardiac Arrest Treatment
8.6.34 Sep 08, 2025: Microbot Medical Receives FDA Clearance for LIBERTY Endovascular Robotic System
8.6.35 Aug 20, 2025: Autonomix Medical Granted New European Patent for First-In-Class Catheter-Based Technology
8.7 Strategy And Business Planning
8.7.1 Feb 09, 2026: Voluntary Announcement Completion of the First Subject Dosing in Phase II Clinical Trial of EDP167
8.7.2 Nov 11, 2025: Expanse Medical Expands to Providence, Rhode Island
8.7.3 Nov 05, 2025: Microbot Medical Commences Limited Market Release of LIBERTY Endovascular Robotic System in the U.S.
8.7.4 Nov 05, 2025: JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics
8.7.5 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.7.6 Sep 23, 2025: LogicMark Introduces Predictive Activity Metrics in Freedom Alert Max Device
8.7.7 Sep 10, 2025: UMaine Opens Labs to SMCC Students for Biomedical Engineering Research
9 Appendix
9.1 Research Methodology
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Market Modeling and Forecasting
9.1.5 Company Share Analysis
9.1.6 Benchmarking
9.2 GlobalData Consulting
9.3 Contact Us
9.4 Disclaimer
